BioXcel Therapeutics Announces Termination of Proposed Public …

NEW HAVEN, Conn., Feb. 13, 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence to develop …


Install CouponFollow Chrome Extension   CouponFollow Extension

$60
OFF

BioXcel Therapeutics Calls Off Proposed $60M Public Offering

6 days from now

Feb 13, 2024  · Less than a week after announcing plans to raise $60 million from inventors, New Haven-based BioXcel Therapeutics Inc. said Tuesday it’s calling off the proposed public offering.

hartfordbusiness.com

$60
OFF

BioXcel Therapeutics Terminates $60 Mln Proposed Public Offering

6 days from now

Feb 13, 2024  · (RTTNews) - Tuesday, BioXcel Therapeutics, Inc. (BTAI) announced the termination of its proposed public offering of $60 million in common stock which was …

businessinsider.com

$60
OFF

BioXcel Therapeutics Announces Termination Of Proposed Public …

6 days from now

BioXcel Therapeutics (NASDAQ:BTAI) on Tuesday said it has terminated its proposed public offering of $60 million of shares of its common stock or, pre-funded warrants to purchase …

msn.com

$60
OFF

BioXcel Therapeutics (BTAI) Terminates Proposed $60M Offering

6 days from now

Feb 13, 2024  · BioXcel Therapeutics, Inc. (Nasdaq: BTAI) today announced that it has terminated its proposed public offering of $60.0 million of shares of its common stock or, in lieu of …

streetinsider.com

$60
OFF

BioXcel Therapeutics Terminates $60 Mln Proposed Public …

6 days from now

Feb 13, 2024  · Tuesday, BioXcel Therapeutics, Inc. (BTAI) announced the termination of its proposed public offering of $60 million in common stock which was previously announced on …

rttnews.com

$60
OFF

BioXcel Therapeutics Announces Termination Of Proposed Public …

6 days from now

Feb 13, 2024  · BioXcel Therapeutics, Inc. today announced that it has terminated its proposed public offering of $60.0 million of shares of its common stock or, in lieu of common stock to …

biospace.com

$60
OFF

BioXcel Therapeutics Announces $60M Proposed Public Offering

6 days from now

Feb 9, 2024  · BioXcel Therapeutics Inc. a New Haven-based biopharmaceutical company, announced a $60 million proposed public offering on Thursday. The firm, which uses artificial …

hartfordbusiness.com

$60
OFF

BioXcel Therapeutics Commences $60 Mln Public Offering; Stock …

6 days from now

Feb 8, 2024  · (RTTNews) - BioXcel Therapeutics Inc. (BTAI) said that it has commenced an underwritten public offering of $60.0 million of shares of its common stock or, in lieu of …

businessinsider.com

$7
OFF

BioXcel Therapeutics Announces Pricing Of $7M Public Offering

6 days from now

23 hours ago  · BioXcel Therapeutics, Inc. (BTAI) Q3 2024 Earnings Call Transcript BioXcel announces common stock and warrants offering, no amount given BioXcel Therapeutics …

seekingalpha.com

$7
OFF

BioXcel Therapeutics Announces $7M Public Offering

6 days from now

21 hours ago  · BioXcel Therapeutics Inc., a New Haven-based biopharmaceutical company that uses artificial intelligence to develop medicines in neuroscience and immuno-oncology, on …

hartfordbusiness.com

$0.00
OFF

BioXcel Therapeutics Prices 5.6M Shares At 48c In Public Offering

6 days from now

1 day ago  · BioXcel Therapeutics announced the pricing of an underwritten public offering of 5,600,000 shares of its common stock, par value $0.001 per share and accompanying …

businessinsider.com

FAQs about BioXcel Therapeutics Announces Termination of Proposed Public … Coupon?

What happened to bioxcel Therapeutics (btai)?

(RTTNews) - Tuesday, BioXcel Therapeutics, Inc. (BTAI) announced the termination of its proposed public offering of $60 million in common stock which was previously announced on February 8, 2024. Following this news stock gained 11%. ...

How much did bioxcel Therapeutics raise in an IPO?

BioXcel Therapeutics (BTAI) raised $60 million in their IPO on Thursday, March 8th 2018. The company issued 5,000,000 shares at a price of $11.00-$13.00 per share. $60 million was raised in the IPO. ...

Who owns bioxcel Therapeutics?

Private Companies own 31% of the shares in BioXcel Therapeutics, Inc. (NASDAQ:BTAI). The general public holds a 24% stake in the company, but they may not have enough influence to sway policy decisions. ...

Will BofA offer a 30-day option to buy shares?

In addition, the Company expects to grant the underwriters a 30-day option to purchase up to $9.0 million of additional shares of common stock at the public offering price, less the underwriting discounts and commissions. BofA Securities and Truist Securities are acting as joint book-running managers for the proposed public offering. ...

Install CouponFollow Extension on Chrome

Install the CouponFollow extension to search for discount codes when shopping the fastest!

Install CouponFollow Chrome Extension   Install CouponFollow Chrome Extension